English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 24, 2026

Analysts say Eli Lilly’s $3.8B AtaiBeckley deal may not trigger psychedelics M&A surge
+ Regulatory
Patient Daily | Jul 24, 2026

AANP extends online conference deadline, offers expanded continuing education for nurse practitioners
+ Pharmaceuticals
Patient Daily | Jul 23, 2026

Biopharma layoffs must double in H2 for 2026 to match previous year’s cuts
+ Pharmaceuticals
Patient Daily | Jul 23, 2026

Study finds persistent fatigue and sleep issues after pandemic, regardless of infection status
+ Pharmaceuticals
Patient Daily | Jul 23, 2026

Causes, symptoms, and treatment options for psychosis in young adults discussed
+ Pharmaceuticals
Patient Daily | Jul 23, 2026

Melatonin supplements not recommended for chronic insomnia, experts say
+ Pharmaceuticals
Patient Daily | Jul 23, 2026

Prime Minister Andy Burnham appoints Yvette Cooper as Health Secretary
+ Pharmaceuticals
Patient Daily | Jul 23, 2026

Eli Lilly reports positive Phase 3 results for retatrutide in obesity and diabetes studies

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation